Platelet-derived growth factor inhibition--a new treatment of pulmonary hypertension in congenital diaphragmatic hernia?
D001549:Benzamides; D000077300:Bosentan; D003131:Combined Modality Therapy; D045422:Continuous Positive Airway Pressure; D004232:Diuretics / Q000627:therapeutic use; D004750:Enteral Nutrition; D015199:Extracorporeal Membrane Oxygenation; D006333:Heart Failure / Q000209:etiology; D006548:Hernia, Diaphragmatic / Q000150:complications* / Q000601:surgery; D065630:Hernias, Diaphragmatic, Congenital; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D000860:Hypoxia / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D016285:Iloprost / Q000627:therapeutic use; D000068877:Imatinib Mesylate; D007231:Infant, Newborn; D008297:Male; D009569:Nitric Oxide / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011687:Purines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use*; D017479:Receptors, Platelet-Derived Growth Factor / Q000037:antagonists & inhibitors*; D000068677:Sildenafil Citrate; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use
D001549:Benzamides; D004232:Diuretics; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011687:Purines; D011743:Pyrimidines; D013449:Sulfonamides; D013450:Sulfones; D009569:Nitric Oxide; D000068877:Imatinib Mesylate; D000068677:Sildenafil Citrate; D017479:Receptors, Platelet-Derived Growth Factor; D016285:Iloprost; D000077300:Bosentan